
Dishman Carbogen Amcis Files FY26 BRSR Report
Dishman Carbogen Amcis Limited has submitted its Business Responsibility and Sustainability Report (BRSR) for the Financial Year ended March 31, 2026. The report, filed as per SEBI regulations, details the company's corporate identity, operational structure, and market presence. Dishman Carbogen Amcis operates as a Contract Development and Manufacturing Organisation (CDMO), with 100% of its turnover derived from the manufacturing of Bulk Drugs & APIs. The company reported a significant export contribution of 94.94% to its total turnover. The report also provides employee statistics, including details on permanent and other than permanent employees and workers, as well as data on differently-abled personnel. It highlights the representation of women in leadership positions, with 33.33% on the Board of Directors and Key Management Personnel.
Key Highlights
- Dishman Carbogen Amcis files FY26 BRSR report.
- Company operates as a CDMO, focusing on Bulk Drugs & APIs.
- Exports constitute 94.94% of total turnover.
- Women hold 33.33% of Board and KMP positions.
- Report covers standalone operational and employee data.
Price Impact
More from DCAL